<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00691314</url>
  </required_header>
  <id_info>
    <org_study_id>2006BAI01A10-2</org_study_id>
    <nct_id>NCT00691314</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis</brief_title>
  <acronym>ESSCAS</acronym>
  <official_title>Safety and Efficacy of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of stent implantation in
      patients with symptomatic extra- and intracranial artery stenosis and to determine its role
      in secondary prevention of ischemic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemic stroke in the supply area of stent implantation artery</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemorrhagic stroke</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemic stroke in the supply area of non-stent implantation artery</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute coronary syndrome</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transient ischemic attack</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of re-stenosis of the stent implantation artery</measure>
    <time_frame>30 days and 1 year after the procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <condition>Atherosclerosis</condition>
  <condition>Stenosis</condition>
  <condition>Stents</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stent implantation (Wingspan, Coroflex, and TiTAN2)</intervention_name>
    <description>Stent Implantation:
Wingspan intracranial stent with Gateway PTA balloon Catheter; Coroflex&amp;reg - balloon expandable stent system and Coroflex Blue - Coronary Stent System; TiTAN2 Bio-active coating stent
Standard Medical Management:including antiplatelet agents(Aspirin 75~150mg/day or Clopidogrel 75mg/day),statins(Atorvastatin 20mg/day or Simvastatin 20mg/day),risk factor lowering agents (antihypertension agents:Amlodipine 5mg/day or Benazepril 10mg/day or Valsartan 80mg/day or Nifedipine 30mg/day or Indapamide 2.5mg/day,antidiabetic agents: Metformin 0.5 tid or Glipizide 5mg tid or Acarbose 50mg tid )if necessary,interactive education program (Online medical education program, health behavior guide) .
Arms: 1</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard medical treatment</intervention_name>
    <description>Standard Medical Management:including antiplatelet agents(Aspirin 75~150mg/day or Clopidogrel 75mg/day),statins(Atorvastatin 20mg/day or Simvastatin 20mg/day),risk factor lowering agents (antihypertension agents:Amlodipine 5mg/day or Benazepril 10mg/day or Valsartan 80mg/day or Nifedipine 30mg/day or Indapamide 2.5mg/day,antidiabetic agents: Metformin 0.5 tid or Glipizide 5mg tid or Acarbose 50mg tid )if necessary,interactive education program (Online medical education program, health behavior guide)</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged between above 40 year-old and 75 year-old.

          2. Ischemic stroke related to extra- and intracranial atherosclerosis stenosis, transient
             ischemic attack (TIA ), onset time within 90 days

          3. Implantation of stent should be at least 1 week after stroke onset, and patient's
             medical condition stable, no time limit for TIA,

          4. Stenosed ICA or MCA or BA or VA is the candidate arteries for stent implantation.

          5. Degree of stenosis of target artery ranges between 51%-99%

          6. Modified Rankin score≤3 or NIHSS Score ≤4

          7. Informed consent is obtained.

        Exclusion Criteria:

        Patients will be excluded from entry if any of the criteria listed below are met:

          1. Target stenosis artery is not suitable for stent implantation after evaluation.

          2. Previous carotid endarterectomy or carotid artery stent ,or intracranial artery stent
             implantation.

          3. Ischemic stroke is caused by conditions other than atherosclerosis .

          4. Documented non-atherosclerosis angiopathy.

          5. Clinically unstable at the time of enrollment,

          6. Conditions which may lead to cardiogenic embolism : arterial fibrillation，left
             ventricular thrombi,Myocardiac infarction within 6 weeks,etc.

          7. Severe hypertension (systolic blood pressure &gt;180 mmHg or diastolic blood pressure
             &gt;110 mmHg)

          8. Severe co-morbid or unstable medical condition, ie，severe heart failure, pulmonary
             failure or renal failure, liver dysfunction (serum liver enzyme twice or more than
             normal level),malignancy with likelihood of death within the next 2 years

          9. Significant memory or behavioral disorder, ie, Alzheimer disease, etc.daily care
             needed.

         10. Concurrent participation in another clinical trial

         11. Unable to return follow up

         12. History of hemorrhagic disease(ie, intracranial hemorrhage, Idiopathic
             Thrombocytopenic Purpura,etc ) or bleeding tendency conditions.

         13. Intracranial arteriovenous malformation or aneurysm.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liying Cui</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xuanwu Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Daping Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing General Hospital of Nanjing Military Command</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Center of Medical Sciences</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The General Hospital Under Tianjin Medical Sciences University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2008</study_first_submitted>
  <study_first_submitted_qc>June 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2008</study_first_posted>
  <last_update_submitted>February 23, 2011</last_update_submitted>
  <last_update_submitted_qc>February 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2011</last_update_posted>
  <responsible_party>
    <name_title>Liying Cui</name_title>
    <organization>Peking Union Medical College Hospital</organization>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Transietn Ischemic Attack</keyword>
  <keyword>Stents</keyword>
  <keyword>Stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

